Publication date context February 13 2026. This regulatory news brief reports on entropy based physiological signal analysis in patients with obstructive sleep apnoea. The study examines Continuous Positive Airway Pressure therapy and is sponsored by King’s College London and the Royal Free Hospital NHS Foundation Trust. The trial status is Not yet recruiting and the ClinicalTrials.gov entry is NCT07406620. This article explains what changed, who should care and how regulators may view the work.
What changed in entropy based physiological signal analysis for obstructive sleep apnoea?
How is entropy based analysis being used?
The entry describes entropy based physiological signal analysis in patients with obstructive sleep apnoea as part of a research approach to CPAP therapy. The focus is on signal complexity in relation to sleep, breathing and treatment outcomes. The source lists the condition and intervention and notes the study is sponsored by two institutions. The exact methods are not detailed in the provided text and no results are reported yet, which is typical for a not yet recruiting study listing on ClinicalTrials.gov.
What regulators will want to know?
Intended use safety and data handling
Regulators would examine the intended use and safety claims tied to a study that involves entropy based signal analysis in conjunction with a CPAP intervention. The source notes the trial status and sponsor and uses a device mode of therapy. This framework would require adherence to MDR Annex XIV language when a device component is introduced into clinical evaluation. The present material does not assert device performance and should be interpreted as an early design stage description rather than a completed regulatory submission.
What evidence exists at this stage?
Current status and data availability
The source states not yet recruiting and provides a link to ClinicalTrials.gov listing NCT07406620. No study results or efficacy data are described in the given text. Readers should expect that future updates would reveal performance and safety data subject to regulatory review.
Who is involved and where is the research hosted?
Institutions and collaboration
The listed sponsors are King’s College London and the Royal Free Hospital NHS Foundation Trust. The collaboration between a university and an NHS hospital aligns with common practice for device oriented sleep research and supports oversight of trial design and data management. The source does not indicate additional sites.
What safety and performance considerations are relevant?
What does the source indicate?
The provided text does not present safety or performance data. It points to a research study involving entropy based analysis in a CPAP context. Any future reporting should address risk management, device performance and data integrity in line with applicable regulatory standards.
FAQ
- 1. What is entropy based physiological signal analysis in this context
The article notes that entropy based analysis is used to study physiological signals in obstructive sleep apnoea and CPAP therapy in a research setting. The current material does not provide data or conclusions.
- 2. Who sponsors the study
The sponsors are King’s College London and the Royal Free Hospital NHS Foundation Trust.
- 3. Where can I read the registry listing
The ClinicalTrials.gov listing is available at NCT07406620.
In short this entropy based analysis study in CPAP treated obstructive sleep apnoea is at an early stage with sponsorship by major UK institutions. Regulators will assess future data on safety and performance before any device claims are approved. Clinicians should monitor registry updates for changes in status or results.
Professional informational purposes only. This article is not legal advice. It is not regulatory guidance.
https://clinicaltrials.gov/study/NCT07406620?term=medical+device